Zhang X - Search Results

1

First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.

Lin Z, Fu S, Zhou Y, Zhang X, Chen C, He LN, Li H, Wang Y, Chen T, Zhang L, Hong S. Lin Z, et al. Among authors: zhang l, zhang x. Lung Cancer. 2019 Nov;137:100-107. doi: 10.1016/j.lungcan.2019.09.007. Epub 2019 Sep 12. Lung Cancer. 2019. PMID: 31568886

2

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.

Zhang X, Rao H, Xu X, Li Z, Liao B, Wu H, Li M, Tong X, Li J, Cai Q. Zhang X, et al. Cancer Sci. 2018 Jan;109(1):199-206. doi: 10.1111/cas.13439. Epub 2017 Dec 28. Cancer Sci. 2018. PMID: 29124835 Free PMC article.

3

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis.

Zhou Y, Chen C, Zhang X, Fu S, Xue C, Ma Y, Fang W, Yang Y, Hou X, Huang Y, Zhao H, Hong S, Zhang L. Zhou Y, et al. Among authors: zhang l, zhang x. J Immunother Cancer. 2018 Dec 22;6(1):155. doi: 10.1186/s40425-018-0477-9. J Immunother Cancer. 2018. PMID: 30577837 Free PMC article.

4

First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy.

Zhou Y, Lin Z, Zhang X, Chen C, Zhao H, Hong S, Zhang L. Zhou Y, et al. Among authors: zhang l, zhang x. J Immunother Cancer. 2019 May 3;7(1):120. doi: 10.1186/s40425-019-0600-6. J Immunother Cancer. 2019. PMID: 31053172 Free PMC article.

5

Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition.

Zhang X, Zhou Y, Chen C, Fang W, Cai X, Zhang X, Zhao M, Zhang B, Jiang W, Lin Z, Ma Y, Yang Y, Huang Y, Zhao H, Xu R, Hong S, Zhang L. Zhang X, et al. Among authors: zhang l, zhang b. J Immunother Cancer. 2019 Nov 21;7(1):322. doi: 10.1186/s40425-019-0808-5. J Immunother Cancer. 2019. PMID: 31753012 Free PMC article.

6

Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.

Chen C, Zhou Y, Zhang X, Fu S, Lin Z, Fang W, Yang Y, Huang Y, Zhao H, Hong S, Zhang L. Chen C, et al. Among authors: zhang l, zhang x. Cancer Med. 2020 Mar;9(5):1721-1732. doi: 10.1002/cam4.2838. Epub 2020 Jan 19. Cancer Med. 2020. PMID: 31955525 Free PMC article. Clinical Trial.

7

Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.

Huang T, Su N, Zhang X, Ma S, Zhong G, Tian X, Chen Q, Tang L, Lu L, Fang Y, Cai J, Cai Q. Huang T, et al. Among authors: zhang x. Head Neck. 2020 Aug;42(8):1970-1980. doi: 10.1002/hed.26130. Epub 2020 Mar 10. Head Neck. 2020. PMID: 32154638

8

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum.

Chen C, Zhang X, Zhou Y, Fu S, Lin Z, Hong S, Zhang L. Chen C, et al. Among authors: zhang l, zhang x. Cancer Manag Res. 2020 Oct 20;12:10353-10360. doi: 10.2147/CMAR.S275947. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116890 Free PMC article.

9

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.

Cai J, Liu P, Huang H, Li Y, Ma S, Zhou H, Tian X, Zhang Y, Gao Y, Xia Y, Zhang X, Yang H, Li L, Cai Q. Cai J, et al. Among authors: zhang x, zhang y. Signal Transduct Target Ther. 2020 Dec 30;5(1):289. doi: 10.1038/s41392-020-00331-3. Signal Transduct Target Ther. 2020. PMID: 33376237 Free PMC article. Clinical Trial.

10

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy.

He LN, Zhang X, Li H, Chen T, Chen C, Zhou Y, Lin Z, Du W, Fang W, Yang Y, Huang Y, Zhao H, Hong S, Zhang L. He LN, et al. Among authors: zhang l, zhang x. Front Oncol. 2021 Jan 19;10:621329. doi: 10.3389/fonc.2020.621329. eCollection 2020. Front Oncol. 2021. PMID: 33552993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,972 results

Search Page

Filters